Related Experiment Videos
[Sonographic first trimester screening in Switzerland].
O Lapaire1, G Sartorius, W Holzgreve
1Universitäts-Frauenklinik Basel. olapaire@uhbs.ch
Praxis
|March 10, 2005
Summary
Nuchal translucency ultrasound is a key screening tool for chromosomal anomalies. Combining it with biochemical markers and maternal age improves risk assessment, reducing the need for invasive procedures.
Area of Science:
- Prenatal diagnosis
- Medical imaging
- Genetics
Background:
- Nuchal translucency (NT) sonography is a primary screening method for fetal chromosomal abnormalities.
- Accurate risk assessment is crucial for informed reproductive decisions.
Purpose of the Study:
- To evaluate the effectiveness of integrating NT sonography with biochemical markers and maternal age for chromosomal anomaly screening.
- To determine the impact of this combined approach on the necessity of invasive diagnostic procedures.
Main Methods:
- Standardized sonographic measurement of nuchal translucency.
- Incorporation of biochemical markers and maternal age into risk calculation algorithms.
- Analysis of screening performance and reduction in invasive procedures.
Main Results:
- Improved accuracy in calculating the specific maternal risk for chromosomal anomalies.
- Significant potential to reduce the number of unnecessary invasive examinations.
- Emphasis on comprehensive patient information and counseling alongside screening.
Conclusions:
- The combined approach of NT sonography, biochemical markers, and maternal age offers superior screening for chromosomal anomalies.
- This strategy enhances prenatal care by optimizing risk assessment and minimizing invasive testing.